0001209191-20-035736.txt : 20200610
0001209191-20-035736.hdr.sgml : 20200610
20200610204623
ACCESSION NUMBER: 0001209191-20-035736
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200608
FILED AS OF DATE: 20200610
DATE AS OF CHANGE: 20200610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fernando Anthony C. J.
CENTRAL INDEX KEY: 0001664960
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 20955967
MAIL ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANSENTERIX, INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSENTERIX INC.
DATE OF NAME CHANGE: 20131210
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
FORMER COMPANY:
FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-08
0
0000876378
TRANSENTERIX, INC.
TRXC
0001664960
Fernando Anthony C. J.
C/O TRANSENTERIX, INC.
635 DAVIS DRIVE, SUITE 300
MORRISVILLE
NC
27560
1
1
0
0
President and CEO
Stock Option
0.82
2020-06-08
4
A
0
550000
0.00
A
2027-06-08
Common Stock
550000
550000
D
Restricted Stock Unit
2020-06-08
4
A
0
160000
0.00
A
Common Stock
160000
160000
D
Restricted Stock Unit
2020-06-08
4
A
0
240000
0.00
A
Common Stock
240000
240000
D
Restricted Stock Unit
2020-06-08
4
A
0
550000
0.00
A
Common Stock
550000
550000
D
The stock options vest one-third annually on each of June 8, 2021, June 8, 2022 and June 8, 2023. Subject to acceleration of vesting in full upon consummation of a change in control of the Registrant.
Each restricted stock unit represents the right to receive one share of the Registrant's common stock.
Forfeiture restrictions will lapse on the restricted stock units in three installments of 53,333, 53,333 and 53,334 on each of February 4, 2021, 2022, and 2023, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Amended and Restated Incentive Compensation Plan and the Reporting Person's Employment Agreement with the Registrant.
Represents performance-based restricted stock units with time-based vesting in three equal installments of 80,000 on each of February 4, 2021, 2022 and 2023, and performance-based vesting only if, during the three year performance period ended June 8, 2023, the Registrant's stock price is equal to or greater than $1.00 for twenty consecutive trading days.
Forfeiture restrictions will lapse on the restricted stock units on the first anniversary of the date of grant, as long as the Reporting Person remains in continuous service during the vesting period.
/s/ Joshua Weingard, as attorney-in-fact for Anthony C.J. Fernando
2020-06-10